Pharmaceuticals

Pharmaceutical application

Evolva focuses on creating and advancing pharmaceutical product candidates that target significant unmet medical needs and that have biosynthetic origins. We are particularly active in infectious disease and metabolic and cardiovascular disorders. Our emphasis is on small-molecule compounds that can be delivered orally.

EV-077 for the treatment of complications of diabetes
Pomecin A for skin care and topical fungal infections
EV-035 addresses the threat of bad bugs
Find out more about our Partnering Approach